XTL Biopharmaceuticals Ltd. (XTLB) |
| 1.9799 0.03 (1.53%) 10-13 16:00 |
| Open: | 1.926 |
| High: | 1.9799 |
| Low: | 1.88 |
| Volume: | 4,287 |
| Market Cap: | 2(M) |
| PE Ratio: | -5.5 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.56 |
| Resistance 1: | 2.30 |
| Pivot price: | 2.13 |
| Support 1: | 1.88 |
| Support 2: | 1.56 |
| 52w High: | 6.24 |
| 52w Low: | 1.92 |
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally established in 1993 as Xenograft Technologies Ltd., the company rebranded to XTL Biopharmaceuticals Ltd. in July 1995. It operates from its headquarters in Ramat Gan, Israel.
Financials
| EPS | -0.360 |
| Book Value | -0.000 |
| PEG Ratio | 2.27 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -21.0 |
| Return on Equity (ttm) | -29.3 |
Company news
Tue, 06 Oct 2026
XTL Biopharmaceuticals (XTLB) Edges Higher as Shares Test $2.29 Resistance - RVOL Spike - https://www.dars.gov.et/
Tue, 06 Oct 2026
XTL Biopharmaceuticals (XTLB) Edges Higher as Shares Test $2.29 Resistance - Island Reversal - siam.in
Mon, 05 Oct 2026
XTLB Stock Edges Higher: XTL Biopharmaceuticals ADR Ticks Up 0.46% to $2.17 - KAMA Signal - https://www.siam.in/
Fri, 22 May 2026
XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com
Wed, 29 Apr 2026
XTLB Stock Spikes On Volume As Traders Eye Breakout - StocksToTrade
Wed, 29 Apr 2026
XTLB Stock Holds Tight As Traders Watch Biotech Penny Setup - Timothy Sykes
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
